Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: Prospective evaluation of a novel technique

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 3, 2013, Pages 386-393

  Nayak, Brusabhanu ^a   Dogra, Prem Nath ^a   Naswa, Niraj ^a   Kumar, Rakesh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

18F FDG; Carcinoma; Diuretic; Furosemide; PET CT; Urinary bladder

Indexed keywords

CONTRAST MEDIUM; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; DIAGNOSTIC AGENT;

ABDOMEN; ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER SURGERY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED COMPUTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYSTECTOMY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIURESIS; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; PELVIS; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSURETHRAL RESECTION OF THE BLADDER TUMOR; BLADDER TUMOR; CLINICAL TRIAL; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SCINTISCANNING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DIURESIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84873993736     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2294-6     Document Type: Article

References (19)

1. Carroll PR. Urothelial carcinoma: cancers of the bladder, ureter, and renal pelvis. In: Tanagho EA, McAninch JW, editors. Smith's general urology. 15th ed. New York: McGraw-Hill; 2000.
2. Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics 2006;26:553-80.
3. Kim JK, Park SY, Ahn HJ, Kim CS, Cho KS. Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging. Radiology 2004;231(3):725-31.
4. Knox MK, Cowan NC, Rivers-Bowerman MD, Turney BW. Evaluation of multidetector computed tomography urography and ultrasonography for diagnosing bladder cancer. Clin Radiol 2008;63(12):1317-25.
5. Husband JE. Computer tomography and magnetic resonance imaging in the evaluation of bladder cancer. J Belge Radiol 1995;78(6):350-5.
6. Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 1994;193(1):239-45.
7. Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 2009;27(26):4314-20.
8. Apolo AB, Riches J, Schöder H, Akin O, Trout A, Milowsky MI, et al. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer. J Clin Oncol 2010;28(25):3973-8.
9. Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L. FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging 2005;32(12):1412-7.
10. Anjos DA, Etchebehere ECSC, Ramos CD, Santos AO, Albertotti C, Camargo EE. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. J Nucl Med 2007;48(5):764-70.
11. Voges GE, Tauschke E, Stöckle M, Alken P, Hohenfellner R. Computerized tomography: an unreliable method for accurate staging of bladder tumors in patients who are candidates for radical cystectomy. J Urol 1989;142(4):972-4.
12. Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 2000;163(6):1693-6.
13. Harney JV, Wahl RL, Liebert M, Kuhl DE, Hutchins GD, Wedemeyer G, et al. Uptake of 2-deoxy 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography. J Urol 1991;145(2):279-83.
14. Schöder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004;34(4):274-92.
15. Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, et al. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 2010;57(4):641-7.
16. Kamel EM, Jichlinski P, Prior JO, Meuwly JY, Delaloye JF, Vaucher L, et al. Forced diuresis improves the diagnostic accuracy of 18F-FDG PET in abdominopelvic malignancies. J Nucl Med 2006;47(11):1803-7.
17. Tekes A, Kamel IR, Imam K, Chan TY, Schoenberg MP, Bluemke DA. MR imaging features of transitional cell carcinoma of the urinary bladder. AJR Am J Roentgenol 2003;180(3):771-7.
18. Kumar R, Loving VA, Chauhan A, Zhuang H, Mitchell S, Alavi A. Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. J Nucl Med 2005;46(11):1819-24.
19. Xiu Y, Bhutani C, Dhurairaj T, Yu JQ, Dadparvar S, Reddy S, et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med 2007;32(2):101-5.